Companies around the world are working on better ways to manage diabetes. Universities and other research institutions are working on finding a cure for diabetes and its complications. We provide an outlet for press releases from these organizations, so that you can better understand what they're working on.Recent Press Releases
- New Lilly Diabetes helpline to Assist People Seeking Solutions to Insulin Affordability.
- OmnipodÂ® Hybrid Closed-Loop Insulin Delivery System Significantly Improves Glycemic Control in Adults with Type 1 Diabetes.
- Tandem Diabetes Care Announces FDA Approval of t:slim X2 Insulin Pump with Basal-IQ Technology; New Predictive Low Glucose Suspend Feature to Launch with Dexcom G6 CGM System Integration.
- FDA Approves World's First Long-Term Implantable Continuous Glucose Monitoring System for Marketing in United States.
- Fully Implantable, Continuous Glucose Monitoring Sensor Provided Accuracy for Six Months in Adolescents and Adults with Type 1 Diabetes.
- Existing drug preserves insulin production in new Type 1 diabetes cases, study finds. See also Kidney drug preserves insulin production in type 1 diabetes patients.
- Survey demonstrating underuse of glucagon rescue kits in type 1 diabetes patients to be presented at the ADA's 78th Scientific Sessions.
- One Drop Announces Blood Glucose Prediction and Automated Decision Support.
- Dreamed Diabetes Granted FDA Authorization to Market Advisor Pro, Offering Personalized Optimization of Insulin Pump Therapy.
- Dexcom G5 Continuous Glucose Monitoring System Now Available on Mobile, Smart Devices for Medicare Patients with Diabetes.
- Senseonics and Beta Bionics Partner on Development of the Bionic Pancreas System.
- Insuletâ€™s OmnipodÂ® DASHâ„˘ Insulin Management System Receives FDA 510(k) Clearance.
- Beta Bionics Receives IDE Approval from the FDA to Begin a Home-Use Clinical Trial Testing the New iLetâ„˘️ Bionic Pancreas System. See also Beta Bionics receives FDA approval to begin bionic pancreas study recruitment.
- Protomer Technologies Takes Top Prize in 2018 Diabetes Innovation Challenge; Revolutionary â€śsmartâ€ť drug could prevent hypoglycemia in people with diabetes.
- T1D Exchange Co-Founder Dana Ball to Step Down as CEO.
- American Diabetes AssociationÂ® Announces Tracey D. Brown, MBA, BChE, as new CEO, effective June 1, 2018.
- Tandem is pleased to introduce AutoSoft XC.
- Tandem Diabetes Care Receives CE Mark for t:slim X2 Insulin Pump.
- Tandem Diabetes Care Announces Agreements for Distribution of Insulin Pump Products in Australia and New Zealand.
- Senseonics Announces Favorable Outcome of FDA Advisory Committee on the Eversense System.
- Lilly and Sigilon Therapeutics Announce Strategic Collaboration to Develop Encapsulated Cell Therapies for the Treatment of Type 1 Diabetes.
To have your press release included on this page, send an e-mail to . Please be sure to include contact information in case we have questions. We reserve the right to include only those press releases that are consistent with our editorial positions.
|Return to the Top of This Page|
Last Updated: Thursday July 19, 2018 00:02:58
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.
This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
© Children with Diabetes, Inc. 1995-2018. Comments and Feedback.